Sub-analysis of geographical variations in the 2-year observational COPTIMIZE trial of patients with relapsing–remitting multiple sclerosis converting to glatiramer acetate
Crossref DOI link: https://doi.org/10.1186/s12883-015-0448-4
Published Online: 2015-10-08
Published Print: 2015-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Ziemssen, Tjalf
Gilgun-Sherki, Yossi
License valid from 2015-10-08